ADHβ Inhibitors

ADHβ inhibitors, also known as alcohol dehydrogenase beta inhibitors, represent a diverse class of chemical compounds designed to modulate the activity of the alcohol dehydrogenase beta (ADHβ) enzyme. ADHβ is a critical enzyme involved in the metabolism of alcohols, particularly ethanol, within the human body. These inhibitors are characterized by their ability to interfere with the enzymatic function of ADHβ, ultimately affecting the conversion of alcohols into their corresponding metabolites. The inhibition of ADHβ activity can lead to altered alcohol metabolism and, consequently, various physiological and biochemical consequences.

Chemically, ADHβ inhibitors exhibit a wide range of structural diversity, including organic compounds such as disulfiram, fomepizole, and pyrazole. Mechanistically, they interfere with the catalytic activity of ADHβ through several different strategies. Some inhibitors act as competitive inhibitors, binding to the active site of the enzyme and competing with the substrate, thereby reducing its enzymatic activity. Others function as irreversible inhibitors by forming covalent bonds with specific amino acid residues within ADHβ, rendering the enzyme permanently inactive. Additionally, some ADHβ inhibitors can act as allosteric modulators, binding to regulatory sites on the enzyme and altering its conformation, which, in turn, affects its enzymatic activity. The specific mechanism of action often depends on the chemical structure of the inhibitor and its binding affinity for ADHβ.